- Overview:
- This study is evaluating an investigational medicine in people having been treated for primary hypothyroidism for at least 12 months.
- Staus:
- Enrolling
- Clinical Description:
- The purpose of this study is to evaluate if an investigational medicine is safe and effective in the treatment of primary hypothyroidism. The study will compare the effect of the investigational medicine on primary hypothyroidism and its safety with Synthetic Drug T4.
- Target Age/Sex:
- 18 to 75 years old, Male & Female
- Benefits:
- You will not be charged for participation in this study.
- Study Length:
- About 90 Weeks
- Sponsor Link:
- https://clinicaltrials.gov/
